LTFS
EPRS

Ladenburg Thalmann Financial Services’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10
Closed – – 5120
2016
Q2 		$0 Sell
10
-89,990
-100% -$145K ﹤0.01% 5088
2016
Q1 		$257K Hold
90,000
– – ﹤0.01% 1444
2015
Q4 		$278K Sell
90,000
-1
-0% -$5 0.01% 1362
2015
Q3 		$464K Buy
90,001
+45,000
+100% +$264K 0.01% 1014
2015
Q2 		$257K Sell
45,001
-2
-0% -$14 ﹤0.01% 1430
2015
Q1 		$403K Buy
45,003
+45,000
+1,500,000% +$361K 0.01% 1154
2014
Q4 		$0 Hold
3
– – ﹤0.01% 4629
2014
Q3 		$0 Buy
+3
New +$26 ﹤0.01% 4227

Other funds holding EPRS

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Ladenburg Thalmann Financial Services's EPRS Position: Q3 2016 in Review

Ladenburg Thalmann Financial Services sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 10 shares.

Ladenburg Thalmann Financial Services first reported a position in EPRS in Q3 2014 and held it in 8 quarters. The position peaked at $464K in Q3 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

  • Ladenburg Thalmann Financial Services reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 10 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016.
  • Ladenburg Thalmann Financial Services first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 8 quarters.
  • Ladenburg Thalmann Financial Services's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $464K in Q3 2015.
  • 3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2016, filed 14 Nov 2016.